Teva, Mylan Back Plan For New Bellwether In Price-Fix MDL
By Nadia Dreid · March 2, 2021, 6:53 PM EST
Mylan, Teva and Par Pharmaceuticals are among a group of generic-drug makers that told a Pennsylvania federal judge Monday they're fine with her plan to swap out a bellwether case in...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login